COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 2114: Articles 21131-21140  | Next

An ancient coronavirus-like epidemic drove adaptation in East Asians from 25,000 to 5,000 years ago
Souilmi, Y., Lauterbur, M. E., Tobler, R., Huber, C. D., Johar, A. S., Enard, D.
10.1101/2020.11.16.385401 — Posted: 2020-11-16
Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation
van Dorp, L., Tan, C. C., Lam, S. D., Richard, D., Owen, C., Berchtold, D., Orengo, C., Balloux, F.
10.1101/2020.11.16.384743 — Posted: 2020-11-16 Discussion: Onsite | Offsite
Transcriptome Profiling of different types of human respiratory tract cells infected by SARS-CoV-2 Highlight an unique Role for Inflammatory and Interferon Response
Yang, M., Lei, L., Cao, Q., Yang, Y., Wang, J., Jiang, X., Huang, K., Lai, J., Qing, L., Wang, Y., Liu, Y.
10.1101/2020.11.15.383927 — Posted: 2020-11-16
Analysis of SARS-CoV-2 spike glycosylation reveals shedding of a vaccine candidate
Brun, J., Vasiljevic, S., Gangadharan, B., Hensen, M., Chandran, A. V., Hill, M. L., Kiappes, J. L., Dwek, R. A., Alonzi, D. S., Struwe, W. B., Zitzmann, N.
10.1101/2020.11.16.384594 — Posted: 2020-11-16
Trimeric SARS-CoV-2 Spike proteins produced from CHO-cells in bioreactors are high-quality antigens
Pino, P., Kint, J., Kiseljak, D., Agnolon, V., Corradin, G., KAJAVA, A. V., Rovero, P., Dijkman, R., Hartog, G. d., McLellan, J. S., Byrne, P., Wurm, M. J., Wurm, F. M.
10.1101/2020.11.15.382044 — Posted: 2020-11-16
Gene Expression Meta-Analysis Identifies Molecular Changes Associated with SARS-CoV Infection in Lungs
Park, A., Harris, L.
10.1101/2020.11.14.382697 — Posted: 2020-11-16
Examining the Persistence of Human Coronaviruses on Fresh Produce
Blondin-Brosseau, M., Harlow, J., Doctor, T., Nasheri, N.
10.1101/2020.11.16.385468 — Posted: 2020-11-16 Discussion: Onsite | Offsite
SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
Li, Z., Liu, J., Deng, H., Yang, X., Wang, H., Feng, X., Zelinskyy, G., Trilling, M., Sutter, K., Lu, M., Wang, B., Yang, D., Zheng, X., Liu, J.
10.1101/2020.11.15.383463 — Posted: 2020-11-16 Discussion: Onsite
Effects of inactivation method on SARS-CoV-2 virion proteins and structure
Loveday, E. K., Hain, K. S., Kochetkova, I., Hedges, J. F., Robison, A., Snyder, D. T., Brumfield, S. K., Young, M. J., Jutila, M. A., Chang, C. B., Taylor, M. P.
10.1101/2020.11.14.383026 — Posted: 2020-11-16
High resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
Garrett, M. E., Galloway, J., Chu, H. Y., Itell, H. L., Stoddard, C. I., Wolf, C. R., Logue, J. K., McDonald, D., Matsen, F. A., Overbaugh, J.
10.1101/2020.11.16.385278 — Posted: 2020-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).